查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957212

心臟去心房顫動市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

Cardiology Defibrillators Devices Sales Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心臟去心房顫動市場預計將從 2025 年的 105.5 億美元成長到 2031 年的 144.6 億美元，複合年成長率為 5.39%。

這些心臟去心房顫動是專門用於向心臟輸送治療性電擊的醫療設備，能夠有效終止危及生命的心律不整，例如室顫，並恢復正常竇性心律。市場成長的主要驅動力是全球人口老化以及需要緊急治療的心血管疾病發生率不斷上升。此外，政府旨在促進在公共場所廣泛使用自動體外心臟去心房顫動（AED）的強制性規定，以及醫療設備的加強，都顯著推動了該行業的擴張。

市場概覽
預測期 2027-2031
市場規模：2025年 105.5億美元
市場規模：2031年 144.6億美元
複合年成長率：2026-2031年 5.39%
成長最快的細分市場 植入式心臟整流去顫器（ICD）
最大的市場 北美洲

然而，該行業面臨著許多挑戰，尤其是嚴格的法規環境和頻繁的產品召回，這些都可能延緩產品上市並增加生產成本。這些障礙阻礙了製造商快速回應由沉重疾病負擔驅動的全球日益成長的需求。正如歐洲心臟學會2024年報告所述，心血管疾病每年在成員國奪走超過300萬人的生命，凸顯了可靠治療性介入的迫切需求。

市場促進因素

心血管疾病和心律不整的日益普遍是全球心臟去心房顫動顫器市場的主要驅動力。全球心臟麻痹（SCA）的發病率上升，使得治療設備的需求迫切，為尋求擴大規模以滿足臨床需求的製造商創造了巨大的商業性機會。這種沉重的疾病負擔也促成了主要產業參與者的強勁財務表現。例如，美敦力在其2024年5月發布的「2024會計年度及第四季財務表現」新聞稿中宣布，其心血管產品組合在該會計年度創造了118.31億美元的收入，凸顯了這些治療性介入的重要性。此類事件發生頻率的不斷增加進一步強調了這種需求。根據猝死基金會於2024年10月發布的「最新統計」報告，心臟麻痹登記系統（CARES）記錄了2024年137,119例院外心臟麻痹病例，顯示有大量患者需要去心房顫動治療。

同時，公共場所去心房顫動（PAD）部署的擴大正在改變整個產業。當局正在增加機場、學校等公共場所自動體外心臟去心房顫動（AED）的安裝，這一策略得到了臨床數據的支持，數據顯示其優於延遲響應。根據猝死基金會2024年10月發布的《猝死真相》報告，在配備AED的醫療機構中，心臟麻痹患者的生存率高達93%，而未配備AED的醫療機構中，這一比例僅為9%。這一顯著差異正在推動法律支持擴大AED的普及範圍和資金籌措，並促進體外去顫器領域的持續銷售成長。

市場挑戰

嚴格的法規結構及其帶來的合規義務是心臟去心房顫動市場成長的主要障礙。由於這些設備被歸類為高風險生命支持技術，因此受到國際衛生機構的嚴格審查。檢驗安全性和有效性的複雜核准程序往往導致產品開發週期漫長。製造商被迫投入大量資金和技術資源以滿足不斷變化的合規標準，這直接增加了生產成本，並限制了可用於研發和創新的資金。因此，先進去心房顫動技術的發布經常被推遲，即使市場需求旺盛，也難以快速進入市場。

這些法規帶來的財務和營運壓力已反映在近期的行業指標中。 MedTech Europe 的一項 2025 年研究表明，根據新的醫療設備法規 (MDR)，醫療設備的認證和維護成本將比先前的指令增加高達 100%，而選擇歐洲作為其首發市場的大型製造商數量將減少 33%。這種法規環境造成了嚴重的瓶頸，迫使企業推遲甚至在某些情況下從關鍵市場撤回拯救生命的心臟器械，從而阻礙了該行業應對日益嚴重的全球心血管疾病負擔的能力。

市場趨勢

在全球心臟去心房顫動市場，一場向無導線和血管外植入式系統的關鍵技術變革正在進行，旨在減少傳統經靜脈導線相關的血管損傷和導線斷裂等長期併發症。這一趨勢推動了相關設備的商業化，這些設備透過將去心房顫動導線置於胸骨下或皮下，有效地避免了對心臟和靜脈的損傷，同時確保了治療效果。美敦力公司在其2024年9月的新聞稿《美敦力公佈EV ICD全球關鍵性試驗最終結果：證實高ATP成功率和有效去心房顫動》中，展示了這一設計演進的成功，其中Aurora EV-ICD系統在終止室性心動過速/室顫發作方面實現了100%的成功率，在終止室性心動過速/室顫發作方面實現了100%的成功率，在起搏過速7%的成功率方面實現了7%。這表明血管外植入可以提供與上一代靜脈植入產品相當的可靠治療。

同時，物聯網 (IoT) 連接的融合正在變革體外去心房顫動 ( AED) 產業，獨立的硬體設備正演變為智慧化的、網路整合的反應節點。這些智慧 AED 旨在自動執行遠端自診斷，以確保隨時可用，並將即時位置資訊傳輸至緊急指揮中心，從而顯著縮短心臟疾病停時進行電擊去顫的時間。對這種互聯生態系統的需求正在推動該領域的巨額投資。例如，Avive Solutions 在 2024 年 4 月發布的題為「Avive Solutions 獲得 5,650 萬美元成長資金」的新聞稿中宣布，該公司已獲得 5,650 萬美元的資金，用於加速其在美國部署互聯 AED 網路，這凸顯了該行業向數據驅動型緊急應變解決方案的轉變。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心臟去心房顫動銷售市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（植入式心臟整流去顫器(ICD)、體外去心房顫動、穿戴式去心房顫動(WCDS)、高級生命維持設備、其他）
    • 依最終使用者（醫院/診所、門診中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心臟去心房顫動銷售市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲心臟去心房顫動銷售市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心臟去心房顫動銷售市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章 中東和非洲心臟去心房顫動銷售市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美心臟去心房顫動市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球心臟去心房顫動銷售市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • ST. Jude Medical, Inc.
  • Heartsine Technologies, Inc.
  • Zoll Medical Corporation
  • Medical Research Laboratories, Inc.
  • Sorin Group
  • Boston Scientific Corporation
  • Physio-Control, Inc.
  • Laerdal Medical Corporation
  • Cardiac Science Corporation
  • Medtronic Physio-Control Corporation
  • Koninklijke Philips NV
  • Nihon Kohden Corporation
  • Cardiac Science, Inc.
  • Stryker Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23460

The Global Cardiology Defibrillators Devices Sales Market is projected to expand from USD 10.55 Billion in 2025 to USD 14.46 Billion by 2031, registering a CAGR of 5.39%. These cardiology defibrillators are specialized medical devices designed to administer therapeutic electrical shocks to the heart, effectively halting life-threatening arrhythmias like ventricular fibrillation and reestablishing a normal sinus rhythm. The market's growth is largely fueled by an aging global population and the increasing incidence of cardiovascular conditions requiring urgent treatment. Furthermore, government mandates aimed at boosting the availability of automated external defibrillators in public areas, combined with enhancements in healthcare infrastructure, are providing significant support for the sector's expansion.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 10.55 Billion
Market Size 2031USD 14.46 Billion
CAGR 2026-20315.39%
Fastest Growing SegmentImplantable Cardioverter Defibrillator (ICDs)
Largest MarketNorth America

However, the industry encounters notable difficulties, particularly regarding strict regulatory environments and frequent product recalls that can postpone market access and increase production expenses. These hurdles impede manufacturers' capacity to quickly satisfy the rising global demand resulting from the substantial disease burden. As reported by the European Society of Cardiology in 2024, cardiovascular disease claimed over 3 million lives annually across its member nations, emphasizing the critical need for dependable therapeutic interventions.

Market Driver

The increasing prevalence of cardiovascular diseases and arrhythmias acts as the main driver for the Global Cardiology Defibrillators Devices Sales Market. As the global incidence of sudden cardiac arrest (SCA) rises, there is an urgent need for therapeutic devices, generating significant commercial activity for manufacturers expanding to meet clinical demands. This high disease burden results in strong financial performance for major industry players; for instance, Medtronic reported in its 'Medtronic Reports Full Year and Fourth Quarter Fiscal 2024 Financial Results' press release in May 2024 that its Cardiovascular Portfolio achieved $11.831 billion in revenue for the fiscal year, highlighting the vital nature of these interventions. The frequency of these events reinforces this necessity; the Sudden Cardiac Arrest Foundation noted in its 'Latest Statistics' report in October 2024 that 137,119 out-of-hospital cardiac arrest incidents were recorded by the Cardiac Arrest Registry to Enhance Survival (CARES) in 2024, indicating a vast patient population requiring potential defibrillation therapy.

Concurrently, the growth of Public Access Defibrillator (PAD) initiatives is transforming the sector. Authorities are increasingly installing automated external defibrillators (AEDs) in public locations such as airports and schools, a strategy supported by clinical data proving their superiority over delayed responses. According to the Sudden Cardiac Arrest Foundation's 'Sudden Cardiac Arrest Facts' report from October 2024, cardiac arrest victims in facilities equipped with an AED have a 93% chance of survival compared to just 9% when no device is present. This significant contrast drives legislative backing for broader accessibility and funding, thereby promoting consistent sales growth within the external device segment.

Market Challenge

Rigorous regulatory frameworks and the associated compliance obligations constitute a major obstacle to the growth of the cardiology defibrillators market. Because these devices are categorized as high-risk, life-sustaining technologies, they undergo intense scrutiny from international health authorities. The intricate approval procedures needed to verify safety and effectiveness often lead to prolonged product development cycles. Manufacturers are forced to allocate significant financial and technical resources to satisfy these evolving compliance standards, which directly increases production costs and limits the funds available for research and innovation. Consequently, the release of advanced defibrillation technologies is frequently stalled, preventing rapid market entry even when demand is high.

The financial and operational pressure resulting from these regulations is reflected in recent industry metrics. A 2025 survey by MedTech Europe indicated that certification and maintenance expenses for medical devices under the new Medical Device Regulation (MDR) have risen by as much as 100% relative to earlier directives, leading to a 33% drop in large manufacturers selecting Europe as their initial launch region. This regulatory environment creates a significant bottleneck, compelling companies to delay or potentially withdraw life-saving cardiac devices from key markets, thereby hampering the industry's ability to address the growing global burden of cardiovascular disease.

Market Trends

The Global Cardiology Defibrillators Devices Sales Market is experiencing a decisive technological shift toward leadless and extravascular implantable systems aimed at reducing long-term complications linked to traditional transvenous leads, such as vascular injury and lead fractures. This trend involves the commercialization of devices where defibrillation leads are placed substernally or subcutaneously, effectively avoiding the heart and veins while ensuring therapeutic potency. Demonstrating the success of this design evolution, Medtronic announced in a September 2024 press release titled 'Medtronic EV ICD global pivotal trial final results demonstrate high ATP success and effective defibrillation' that the Aurora EV-ICD system attained a 100% success rate for terminating ventricular tachycardia/ventricular fibrillation episodes via shocks and a 77% success rate for anti-tachycardia pacing, proving that extravascular configurations can deliver reliable therapy comparable to transvenous predecessors.

Simultaneously, the external defibrillator segment is being reshaped by the integration of Internet of Things (IoT) connectivity, turning standalone hardware into intelligent, network-integrated response nodes. These smart AEDs are designed to automatically perform remote self-diagnostics to ensure operational readiness and transmit real-time location data to emergency dispatchers, drastically shortening the critical time-to-shock window during cardiac events. The demand for such connected ecosystems is driving substantial investment capital into the sector; for example, Avive Solutions revealed in an April 2024 press release titled 'Avive Solutions Raises $56.5M in Growth Funding' that the company secured $56.5 million to accelerate the deployment of its connected AED network across the United States, underscoring the industry's pivot toward data-driven emergency response solutions.

Key Market Players

  • ST. Jude Medical, Inc.
  • Heartsine Technologies, Inc.
  • Zoll Medical Corporation
  • Medical Research Laboratories, Inc.
  • Sorin Group
  • Boston Scientific Corporation
  • Physio-Control, Inc.
  • Laerdal Medical Corporation
  • Cardiac Science Corporation
  • Medtronic Physio-Control Corporation
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Cardiac Science, Inc.
  • Stryker Corporation

Report Scope

In this report, the Global Cardiology Defibrillators Devices Sales Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiology Defibrillators Devices Sales Market, By Product

  • Implantable Cardioverter Defibrillator (ICDs)
  • External Defibrillator
  • Wearable Cardioverter Defibrillator (WCDS)
  • Advanced Life Support Units
  • Others

Cardiology Defibrillators Devices Sales Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Cardiology Defibrillators Devices Sales Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiology Defibrillators Devices Sales Market.

Available Customizations:

Global Cardiology Defibrillators Devices Sales Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiology Defibrillators Devices Sales Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Implantable Cardioverter Defibrillator (ICDs), External Defibrillator, Wearable Cardioverter Defibrillator (WCDS), Advanced Life Support Units, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cardiology Defibrillators Devices Sales Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiology Defibrillators Devices Sales Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Cardiology Defibrillators Devices Sales Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Cardiology Defibrillators Devices Sales Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End User

7. Europe Cardiology Defibrillators Devices Sales Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiology Defibrillators Devices Sales Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End User
    • 7.3.2. France Cardiology Defibrillators Devices Sales Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Cardiology Defibrillators Devices Sales Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Cardiology Defibrillators Devices Sales Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Cardiology Defibrillators Devices Sales Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End User

8. Asia Pacific Cardiology Defibrillators Devices Sales Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiology Defibrillators Devices Sales Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End User
    • 8.3.2. India Cardiology Defibrillators Devices Sales Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Cardiology Defibrillators Devices Sales Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Cardiology Defibrillators Devices Sales Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Cardiology Defibrillators Devices Sales Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End User

9. Middle East & Africa Cardiology Defibrillators Devices Sales Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiology Defibrillators Devices Sales Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Cardiology Defibrillators Devices Sales Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Cardiology Defibrillators Devices Sales Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End User

10. South America Cardiology Defibrillators Devices Sales Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiology Defibrillators Devices Sales Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Cardiology Defibrillators Devices Sales Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Cardiology Defibrillators Devices Sales Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiology Defibrillators Devices Sales Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ST. Jude Medical, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Heartsine Technologies, Inc.
  • 15.3. Zoll Medical Corporation
  • 15.4. Medical Research Laboratories, Inc.
  • 15.5. Sorin Group
  • 15.6. Boston Scientific Corporation
  • 15.7. Physio-Control, Inc.
  • 15.8. Laerdal Medical Corporation
  • 15.9. Cardiac Science Corporation
  • 15.10. Medtronic Physio-Control Corporation
  • 15.11. Koninklijke Philips N.V.
  • 15.12. Nihon Kohden Corporation
  • 15.13. Cardiac Science, Inc.
  • 15.14. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer